Japan manufacturers’ mood rebounds in Jan, outlook stays flat – Reuters Poll
By Kantaro Komiya TOKYO (Reuters) – Japanese manufacturers’ sentiment recovered in January after a dip last month thanks to better conditions for materials industries, but their outlook remains flat due to uncertainty over proposed Trump policies, the Reuters Tankan poll found. The
Pfizer appeals denial of $75 million claim in SEC case against Cohen hedge fund
NEW YORK (Reuters) – Pfizer (NYSE:PFE) on Tuesday appealed a federal judge’s refusal to award the drugmaker $75.2 million from a more than decade-old insider trading settlement involving billionaire Steven A. Cohen’s former hedge fund, SAC Capital Management. The
US FTC finds major pharmacy benefit managers inflated drug prices for $7.3 billion gain
By Ahmed Aboulenein and Amina Niasse WASHINGTON (Reuters) -The nation’s three largest pharmacy benefit managers have significantly marked up the prices of certain medicines, including for heart disease, cancer and HIV, at their affiliated pharmacies, the U.S. Federal Trade Commission said